Stage changes · close of Oct 13, 2026
Stocks that entered Stage 2 on Oct 13, 2026
6 entered Stage 2, 19 entered Stage 4, 30 entered Stage 3 and 7 entered Stage 1, among US stocks above our tradable floor ($5 and $1 million a day). Each row is that day's close, largest companies first.
From a base into Stage 2 (3)
A new advance: the stock left its base and its trend turned up.
Back into Stage 2 after a pause (3)
The uptrend resumed after a spell of topping action.
Into Stage 4 (19)
A decline began: the stock broke down below its trend.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| EXRExtra Space Storage | Real Estate | $133.74 | -0.2% | -11.5% | 51 | Stage 3 | $28.3B |
| QQnity Electronics | Information Technology | $122.90 | -0.3% | — | — | Stage 3 | $25.7B |
| CPRTCopart | Industrials | $26.37 | -0.4% | -42.4% | 27 | Stage 1 | $24.4B |
| ZWSZurn Elkay Water Solutions | Industrials | $47.19 | +0.7% | -11.1% | 56 | Stage 3 | $7.8B |
| PPCPilgrim's Pride | Consumer Staples | $28.79 | 0.0% | -34.2% | 35 | Stage 1 | $6.9B |
| CAGConAgra Brands | Consumer Staples | $13.70 | +0.1% | -29.0% | 38 | Stage 1 | $6.5B |
| VSECVSE | Industrials | $163.23 | -2.5% | -32.9% | 57 | Stage 3 | $4.6B |
| IBOCInternational Bancshares | Financials | $67.36 | -0.6% | -12.6% | 56 | Stage 3 | $4.2B |
| XENEXenon Pharmaceuticals | Health Care | $34.42 | -3.9% | -51.5% | 43 | Stage 3 | $3.3B |
| CLSKCleanSpark | Financials | $10.15 | -1.5% | -56.3% | 23 | Stage 3 | $2.6B |
| SAHSonic Automotive | Consumer Discretionary | $61.06 | +0.4% | -45.5% | 44 | Stage 3 | $1.9B |
| ALGAlamo Group | Industrials | $154.83 | +1.4% | -28.7% | 42 | Stage 1 | $1.9B |
| NBHCNational Bank Holdings | Financials | $37.56 | -1.3% | -19.6% | 58 | Stage 3 | $1.7B |
| NKTRNektar Therapeutics | Health Care | $37.92 | -4.8% | -62.2% | 32 | Stage 3 | $1.3B |
| TNDMTandem Diabetes Care | Health Care | $16.65 | +1.2% | -41.1% | 67 | Stage 3 | $1.2B |
| SMPStandard Motor Products | Consumer Discretionary | $37.03 | +1.7% | -15.9% | 53 | Stage 3 | $827M |
| PINEAlpine Income Property Trust | Real Estate | $18.36 | +0.3% | -14.1% | 83 | Stage 3 | $329M |
| SLGLSol-Gel Technologies | Health Care | $68.30 | -5.7% | -30.3% | 90 | Stage 3 | $224M |
| RSIRush Street Interactive | Consumer Discretionary | $19.07 | +1.9% | -44.8% | 56 | Stage 3 | — |
Into Stage 3 (30)
The advance stalled and the stock started to move sideways near its high.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| MARMarriott International | Consumer Discretionary | $371.50 | +0.6% | -7.5% | 81 | Stage 4 | $96.9B |
| EPDEnterprise Products Partners | Energy | $36.04 | +0.4% | -8.4% | 71 | Stage 2 | $77.8B |
| ROSTRoss Stores | Consumer Discretionary | $225.68 | -0.1% | -11.4% | 85 | Stage 2 | $72.1B |
| PRUPrudential Financial | Financials | $113.41 | 0.0% | -8.3% | 68 | Stage 2 | $39.1B |
| EXPEExpedia Group | Consumer Discretionary | $273.44 | +1.9% | -19.3% | 75 | Stage 2 | $32.8B |
| ARESAres Management | Financials | $115.62 | -2.1% | -32.5% | 42 | Stage 2 | $26.3B |
| LPLALPL Financial Holdings | Financials | $325.63 | -1.4% | -17.0% | 56 | Stage 2 | $25.6B |
| BCHBanco De Chile ADS | Financials | $39.10 | +0.4% | -10.5% | 78 | Stage 2 | $19.7B |
| CFCF Industries Holdings | Materials | $117.25 | +2.3% | -15.8% | 78 | Stage 2 | $17.7B |
| BENFranklin Templeton | Financials | $31.18 | -2.0% | -11.9% | 82 | Stage 2 | $15.8B |
| BSACBanco Santander | Financials | $32.18 | 0.0% | -11.0% | 73 | Stage 2 | $15.2B |
| EGEverest Group | Financials | $374.72 | +0.6% | -5.5% | 60 | Stage 2 | $14.4B |
| AEGAegon Ltd. New York Registry Shares | Financials | $8.33 | +0.4% | -10.2% | 64 | Stage 2 | $12.3B |
| JKHYJack Henry & Associates | Information Technology | $153.08 | +2.3% | -19.6% | 55 | Stage 2 | $10.7B |
| AREAlexandria Real Estate Equities | Real Estate | $43.82 | -0.7% | -40.3% | 28 | Stage 2 | $7.5B |
| KMXCarMax | Consumer Discretionary | $50.81 | +0.2% | -20.9% | 66 | Stage 2 | $7.2B |
| NICNicolet Bankshares | Financials | $163.33 | -0.5% | -8.6% | 73 | Stage 2 | $3.4B |
| TOWNTowne Bank | Financials | $34.92 | -0.2% | -9.2% | 63 | Stage 2 | $3.2B |
| GBDCGolub Capital BDC | Financials | $12.09 | -0.2% | -7.8% | 53 | Stage 2 | $3.1B |
| FIZZNational Beverage | Consumer Staples | $32.99 | +2.6% | -3.3% | 51 | Stage 2 | $3.1B |
| BANRBanner | Financials | $66.60 | -0.3% | -10.0% | 62 | Stage 2 | $2.4B |
| ATHMAutohome | Communication Services | $20.35 | -0.4% | -25.0% | 38 | Stage 2 | $2.3B |
| FCFFirst Commonwealth Financial | Financials | $19.98 | -0.3% | -8.4% | 73 | Stage 2 | $2.0B |
| HQHabrdn Healthcare Investors | Financials | $19.13 | -3.0% | -20.3% | 65 | Stage 2 | $1.1B |
| ANROAlto Neuroscience | Health Care | $22.09 | -8.5% | -39.7% | 98 | Stage 2 | $867M |
| SHBIShore Bancshares | Financials | $22.47 | 0.0% | -8.1% | 83 | Stage 2 | $750M |
| FTHFaeth Therapeutics | Health Care | $21.51 | -7.5% | -46.3% | 93 | Stage 2 | $555M |
| COFSChoiceOne Financial Services | Financials | $32.49 | -0.7% | -5.3% | 71 | Stage 2 | $486M |
| FRSTPrimis Financial | Financials | $15.37 | +0.1% | -7.8% | 86 | Stage 2 | $381M |
| YARWYarrow Bioscience | Health Care | $18.60 | -6.2% | -56.7% | 91 | Stage 2 | $173M |
Into Stage 1 (7)
A decline ended and the stock started to base.
| Stock | Sector | Close | Day | From 52-week high | RS rank | From stage | Market cap |
|---|---|---|---|---|---|---|---|
| RMBSRambus | Information Technology | $98.17 | -2.8% | -42.5% | 60 | Stage 4 | $10.6B |
| MATMattel | Consumer Discretionary | $16.80 | +0.2% | -24.2% | 51 | Stage 4 | $4.8B |
| LUNRIntuitive Machines | Industrials | $12.18 | -5.3% | -73.3% | 52 | Stage 4 | $2.0B |
| LKFTLakefront Biotherapeutics | Health Care | $29.05 | -1.8% | -16.1% | 42 | Stage 4 | $1.9B |
| TCITranscontinental Realty Investors | Real Estate | $48.76 | -2.4% | -17.2% | 61 | Stage 4 | $428M |
| OPTXSyntec Optics Holdings | Information Technology | $7.66 | -2.4% | -45.7% | 98 | Stage 3 | $309M |
| PMIPicard Medical | Health Care | $15.33 | +35.2% | -97.7% | 4 | Stage 4 | $35.9M |
Stage changes come from our stage analysis of each stock after the close; a change can reverse in the following sessions. Nothing here is investment advice.